Amdocs (DOX) just released Q4 and full year fiscal 2026 results that aligned with prior guidance, while its fiscal 2027 outlook indicated weaker revenue and profit expectations related to issues with T-Mobile. Amdocs shares have climbed recently, with a 30 day share price return of 7.42% and a 90 day share price return of 12.91%. However, the year to date share price return is down 22.12% and the 1 year total shareholder return has declined 22.45%, pointing to improving short term momentum after a tougher longer run. Contrast Amdocs' recent swings with a curated set of software and tech peers that combine quality fundamentals with compressed valuations by scanning our 35 high quality undervalued stocks today.
We show the main point publicly. Create a free account to continue reading the full article, save it, discuss it, and connect it with market and OSINT context.